Citron Research's Andrew Left, who recently issued a $40 price target on Palantir ($PLTR), is facing securities fraud charges for alleged market manipulation. Investors should be aware that his $PLTR short call comes amidst a legal battle where he is accused of pushing misleading stock recommendations for personal profit. A pre-trial hearing is set for August 18, 2025.